NCT06552221View on ClinicalTrials.gov

Finistere Myeloma Observatory (OMYFIN)

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 15, 2022

Study Completion Date

June 30, 2023

Conditions

Multiple Myeloma

Trial Locations (1)

29200

CHRU de Brest, Brest

All Listed Sponsors

lead

University Hospital, Brest

OTHER

NCT06552221 - Finistere Myeloma Observatory (OMYFIN) | Biotech Hunter | Biotech Hunter